Use of Ceramide C16:0 and Ceramide Synthase 6 in the Treatment and Diagnosis of Multiple Sclerosis
The C16:0-ceramide biomarkers described here, allow both the diagnosis and monitoring of autoimmune disease multiple sclerosis. Moreover the ceramide synthase 6 (CerS6) outlined in this invention serves as target for the treatment of MS.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Faster, more energy-efficient way to manufacture an industrially important chemical
Zirconium combined with silicon nitride enhances the conversion of propane — present in natural gas — needed to create in-demand plastic, polypropylene. Polypropylene is a common type of plastic found…
Energy planning in Ghana as a role model for the world
Improving the resilience of energy systems in the Global South. What criteria should we use to better plan for resilient energy systems? How do socio-economic, technical and climate change related…
Artificial blood vessels could improve heart bypass outcomes
Artificial blood vessels could improve heart bypass outcomes. 3D-printed blood vessels, which closely mimic the properties of human veins, could transform the treatment of cardiovascular diseases. Strong, flexible, gel-like tubes…
